Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:BCLI
Tag: NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
June 26, 2020
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
April 3, 2020
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
March 13, 2020
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Entry into a...
ME Staff 8-k
-
March 9, 2020
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Submission of Matters...
ME Staff 8-k
-
December 12, 2019
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
September 9, 2019
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
March 12, 2019
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
November 30, 2018
0
Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) price target set to $9.00 by...
ME Staff
-
September 13, 2018
0
Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) price target set to $11.00 by...
ME Staff
-
August 27, 2018
0
1
2
3
Page 1 of 3
/* */
// AST – IMS - [MarketExclusive_ROS]
Edit with Live CSS